BRCA2 and ovarian cancer: One of the three most frequent variants in BRCA2 gene, K923Qfs*13 mutation had only been reported in Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA), while N1279S previously reported in Cypriot population with familial breast and/or ovarian cancer and in USA with breast cancer [[32], [33], [34]].